3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
47
Polycystic Ovary Syndrome
6
Infertility
2
Hyperandrogenism
2
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunction, Physiological
1
Prostatic Intraepithelial Neoplasia
1
Prostate Adenocarcinoma
1
Primary Dysautonomias
1
Overweight
1
Ovarian Neoplasms
1
Oligomenorrhea
1
Neoplasm Metastasis
1
Metabolic Syndrome
1
Kidney Diseases
1
Insulin Resistance
1
Hypertension
1
Hirsutism
1
Castration-resistant Prostate Cancer
1
Carcinoma, Ovarian Epithelial
1
Anovulation
1
Amenorrhea
1
Adenocarcinoma
1
Interventions
relacorilant
5
Nutrition Assessment
4
Hydrochlorothiazide
3
Amlodipine
3
aliskiren
2
Osilodrostat
2
Lisinopril
2
Bevacizumab
2
Adrenalectomy
2
sacubitril and valsartan sodium hydrate drug combination
1
pembrolizumab
1
pazopanib
1
lutetium Lu 177 dotatate
1
ganirelix
1
gallium Ga 68 dotatate
1
fimasartan
1
enzalutamide
1
clevidipine
1
cediranib
1
bicalutamide
1
benazepril
1
Vitamin D
1
Tumor Necrosis Factors
1
Thiazides
1
Therapeutics
1
Surveys and Questionnaires
1
Sulindac
1
Sodium Chloride
1
Resistance Training
1
Receptors, Androgen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hypertension
×
Flutamide
×
Clear all
NCT05700903
2026-03-02
ARCH
University of Colorado, Denver
Phase 4
Completed
10 enrolled